Do generics producers have what it takes to tackle complex and specialty drugs?
Complex and specialty generics offer high rewards, but their development also comes with operational risks.
By
Complex and specialty generics offer high rewards, but their development also comes with operational risks.
ByThe combined company will focus on obtaining regulatory clearance and commercialisation of ARS’ neffy nasal spray.
Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, even though most insulin is currently produced…
ByPharmaceutical Technology does a roundup of regulatory decisions from late April to early May that impact drugs and the CMOs…
ByRussia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
ByIn the first edition of Pharmaceutical Technology’s series on the FDA’s orphan drug program, we examine how its popularity has…
ByCMOs have been increasingly adopting the use of continuous manufacturing for biologics production following FDA approval.
ByGlobalData’s Drugs Database reveals that more than 490 unique drugs have been discovered using AI-based technologies.
ByThank you for subscribing to Pharmaceutical Technology